Medical News

RSS

Aptiom receives FDA approval to treat seizures associated with epilepsy

The U.S. Food and Drug Administration today approved Aptiom (eslicarbazepine acetate) as an add-on medication to treat seizures associated with epilepsy.

10 Nov 2013

COPD linked to mild cognitive impairment risk

Research shows that elderly patients with chronic obstructive pulmonary disease are nearly twice as likely as those without to have mild cognitive impairment.

8 Nov 2013

Adherence to suicide risk assessment urged for schizophrenia patients

Many patients with schizophrenia who attempt suicide after hospital discharge missed out on a pre-discharge suicide risk assessment, shows a study from Denmark. .

8 Nov 2013

Mood disorder subtypes remain in the family

Psychosis, mania, and depression are unlikely to have shared hereditary causes, report researchers in Molecular Psychiatry.

8 Nov 2013

Olympus hosts fourth annual neuroimaging symposium on functional brain imaging with cellular resolution

Olympus is hosting its fourth annual neuroimaging symposium in conjunction with the 2013 meeting of the Society for Neuroscience (SfN) on Monday, November 11 in San Diego. The Olympus Neuroimaging Symposium will be held near the Convention Center at the San Diego Marriott Marquis and Marina, San Diego Ballroom – Salon A, beginning at 6:30pm. The symposium and reception are open to all media and SfN registered attendees.

From Evident Corporation - Life Sciences 8 Nov 2013

First Edition: November 8, 2013

Today's headlines include coverage of President Barack Obama's apology to people who lost their individual market health coverage because of requirements of the health law.

8 Nov 2013

Covidien fourth quarter net sales increase 2% to $2.56 billion

Covidien plc today reported results for the fourth quarter of fiscal 2013 (July - September 2013). Fourth-quarter net sales of $2.56 billion increased 2% from the $2.50 billion in the fourth quarter a year ago. Foreign exchange rate movement lowered the quarterly sales growth rate by three percentage points.

8 Nov 2013

New recommendations for patients with congenital heart disease

The diagnosis and treatments of congenital heart disease have improved so much that many babies now born with heart defects can still look forward to a long and fulfilling life. Just two generations ago, the majority of babies born with heart defects died before their first birthday, but today many of these conditions can be corrected.

8 Nov 2013

Cancer detection programme using PENTAX Medical equipment achieves remarkable results

PENTAX Medical equipment has been used to set up a pioneering head and neck cancer detection programme at a hospital Trust in Coventry, which has achieved remarkable results; reduced the length of time the patient stays in hospital and reduced costs.

From PENTAX Medical Company 8 Nov 2013

Patrys gets second US patent for anti-cancer product PAT-LM1

Patrys Limited, a clinical stage biotechnology company is pleased to advise that it has been granted a second US patent for lead anti-cancer product PAT-LM1.

8 Nov 2013

Breast cancer drug appears to protect cells against UV radiation, inflammation

Exemestane, a synthetic steroid drug widely prescribed to fight breast cancers that thrive on estrogens, not only inhibits the production of the hormone, but also appears to protect cells throughout the body against damage induced by UV radiation, inflammation and other assaults, according to results of research by Johns Hopkins scientists.

8 Nov 2013

Drug formulation services for highly potent active pharmaceutical ingredients provided by Evonik

Evonik Industries has broadened its capabilities in finished drug product formulation and clinical supply manufacturing and can now handle drug products containing highly potent active pharmaceutical ingredients (HPAPIs) in Darmstadt, Germany, and Birmingham, Alabama/USA. Investments in high containment facilities and upgrades in the laboratory and GMP areas in Birmingham enable Evonik to handle HPAPIs with occupational exposure limits (OEL) as low as 0.1μg/m3 and in Darmstadt as low as 1 μg/m3. Starting 2014, OEL as low as 0.1μg/m3 will also be possible in Darmstadt.

8 Nov 2013

Government spending cuts within NHS increase risk of Clostridium difficile infection

72% of clinicians believe that Government spending cuts within the NHS increase the risk of hospital acquired infections. The ‘Think C-differently’ report, which advises on the current Clostridium difficile landscape, found that despite stringent measures to manage and control Clostridium difficile infection, the NHS is still battling to keep infection rates to a minimum.

8 Nov 2013

Volition’s NuQ-5mc assay detects 75% of patients with colorectal cancer

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today announces the publication of preliminary data from an ongoing independent trial of one of its NuQ assays.

8 Nov 2013

Allied Healthcare Group commences first shipment of CardioCel into Europe

Allied Healthcare Group today announces it has commenced shipment of CardioCel into Europe after the Company received its first orders for the product from outside of Australia.

8 Nov 2013

New outbreak of polio in Syria may endanger neighbouring regions, warn experts

Two infectious disease experts have written to The Lancet warning that a new outbreak of polio (due to infection with wild-type polio virus 1, WPV1) in Syria, recently confirmed by WHO, might endanger neighbouring regions, including Europe.

8 Nov 2013

GLP-1 hormone can predict metabolic efficacy of gastric bypass

The sensitivity of the GLP-1 hormone, which is secreted by the gastrointestinal tract, can predict the metabolic efficacy of a gastric bypass. The use of a GLP1 challenge could thus function as a novel predictive biomarker for personalized treatment of type 2 diabetes and obesity.

8 Nov 2013

Peptide from cow's milk exhibits potent anticancer capability against human stomach cancer cell cultures

New research from a team of researchers in Taiwan indicates that a peptide fragment derived from cow's milk, known as lactoferricin B25 (LFcinB25), exhibited potent anticancer capability against human stomach cancer cell cultures.

8 Nov 2013

New Torquers announced by Qosina

Qosina is pleased to announce the addition of three new Torquers, #97344 for use with guide wires 0.008 inch - 0.018 inch (0.20 mm - 0.46 mm, 0.6 FR - 1.4 FR) and #97345 or #97346 which fit 0.014 inch - 0.038 inch (0.36 mm - 0.96 mm, 1.1 FR - 3 FR). Torquer #97346 has a narrow profile design which is smaller and lighter than the other two.

8 Nov 2013

Academy of Nutrition and Dietetics applauds FDA’s efforts to reduce PHOs in processed foods

The Academy of Nutrition and Dietetics applauds the Food and Drug Administration's efforts, announced November 7, to reduce partially hydrogenated oils in processed foods.

8 Nov 2013